The federal government’s plan to push patented drug prices lower continues to meet with controversy. The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) have aroused criticism from
Browse Posts by Tag
Access
Action
Advocacy
Asbestos
Awareness
Breast Cancer
Canada
Canadian Cancer Survivor Network
Cancer
Cancer Care
Cancer Prevention
Cancer Survivors
CAPO
Caregiving
CCSNPoli
CdnPoli
Cost
Drug Approval
Election
Guest Post
Health
Healthcare
Insurance
Jackie Manthorne
Lung Cancer
Mammogram
Medical Cannabis
Medical Marijuana
Melanoma
Mesothelioma
Metastatic Breast Cancer
Nova Scotia
Oncology
OnPoli
Ontario
Ottawa
Patients
PCPA
Prostate Cancer
Quebec
Research
Smoking
Survey
Survivor
Webinar